Grupo Aval Acciones Y Valores S.A.'s income statement, balance sheet and cash flow statement as filed with the SEC (10-K and 10-Q), with the latest fiscal years and quarters. In its latest fiscal year (Dec 31, 2025 · FY), Grupo Aval Acciones Y Valores S.A. reported net income of $4.6T (+47.3% year on year).
| Line item | Dec 31, 2025 · FY | Dec 31, 2024 · FY | Dec 31, 2023 · FY | Dec 31, 2022 · FY |
|---|---|---|---|---|
| Loan portfolio | $22.5T | $25.5T | $26.5T | $17.6T |
| Cash and cash equivalents and other accounts receivable | $506.0B | — | — | — |
| Investments in debt securities | $2.9T | $2.7T | $2.4T | $1.8T |
| Total interest income | $25.9T | $28.2T | $28.9T | $19.4T |
| Deposits | ($13.1T) | ($15.2T) | ($16.2T) | ($7.8T) |
| Financial obligations | ($5.0T) | ($5.7T) | ($6.4T) | ($3.9T) |
| Total interest expense | ($18.0T) | ($20.9T) | ($22.6T) | — |
| Net interest income | $7.9T | $7.3T | $6.3T | $7.7T |
| Loans and other accounts receivable | ($4.3T) | ($4.8T) | ($4.8T) | ($3.1T) |
| Other financial assets | ($6.9B) | ($4.2B) | $12.9B | ($16.7B) |
| Recovery of charged-off financial assets | $736.3B | $574.3B | $555.8B | $644.0B |
| Impairment losses net of recoveries | ($3.5T) | ($4.2T) | ($4.2T) | ($2.5T) |
| Net interest income, after impairment losses | $4.3T | $3.1T | $2.1T | $5.2T |
| Income from commissions and fees | $4.8T | $4.6T | $4.4T | $3.9T |
| Expenses from commissions and fees | ($1.1T) | ($1.0T) | ($1.0T) | ($970.7B) |
| Net income from commissions and fees | $3.7T | $3.6T | $3.4T | $2.9T |
| Income from sales of goods and services | $10.4T | $11.0T | $11.2T | $12.1T |
| Costs and expenses of sales goods and services | ($8.3T) | ($8.6T) | ($8.0T) | ($7.6T) |
| Gross profit from sales of goods and services | $2.1T | $2.5T | $3.2T | $4.5T |
| Net trading income (loss) | $1.4T | $1.4T | ($916.0B) | $1.6T |
| Net income from other financial instruments mandatorily at fair value through profit or loss | $623.2B | $350.9B | $323.7B | $278.8B |
| Other income | $1.4T | $890.7B | $3.8T | ($848.6B) |
| Other expenses | ($8.9T) | ($8.7T) | ($8.3T) | ($7.4T) |
| Net income before tax expense | $4.6T | $3.1T | $3.5T | $6.3T |
| Income tax expense | ($1.4T) | ($946.4B) | ($1.3T) | ($2.3T) |
| Net income from continuing operations | $3.2T | $2.2T | $2.2T | $4.0T |
| Net income from discontinued operations, net of tax | $26.6B | — | — | $866.2B |
| Net income for the period from continuing operations | $1.7T | $1.0T | $739.0B | $1.9T |
| Net income for the period from discontinued operations | $18.4B | — | — | $594.0B |
| Owners of the parent | $1.7T | $1.0T | $739.0B | $2.5T |
| Net income for the period from continuing operations | $1.5T | $1.2T | $1.4T | $2.1T |
| Net income for the period from discontinued operations | $8.3B | — | — | $272.2B |
| Non-controlling interests | $1.5T | $1.2T | $1.4T | $2.4T |
| Net income for the year | $3.2T | $2.2T | $2.2T | $4.9T |
| Net income per share basic (in Colombian pesos) see note 25 | $72.52 | $42.75 | $31.12 | $107.29 |
| Net income per share diluted (in Colombian pesos) see note 25 | $72.52 | $42.75 | $31.12 | $107.29 |
| Line item | Dec 31, 2025 · FY | Dec 31, 2024 · FY | Dec 31, 2023 · FY | Dec 31, 2022 · FY |
|---|---|---|---|---|
| Cash and cash equivalents | $19.4T | $17.0T | $18.6T | $17.0T |
| Trading assets | $29.1T | $20.2T | $15.5T | $11.8T |
| Investment securities | $39.3T | $39.2T | $34.4T | $33.7T |
| Hedging derivative assets | $236.6B | $54.0B | $48.7B | $20.9B |
| Commercial | $108.3T | $116.1T | $107.4T | $110.7T |
| Interbank and overnight funds | $1.8T | — | — | — |
| Commercial, interbank and overnight funds | $110.1T | — | — | — |
| Consumer | $60.5T | $62.0T | $60.0T | $59.4T |
| Mortgages | $22.1T | $22.0T | $18.5T | $17.9T |
| Microcredit | $1.5B | $4.4B | $277.5B | $267.7B |
| Total loans, gross | $192.7T | $200.1T | $186.2T | — |
| Loss allowance | ($8.4T) | ($10.0T) | ($10.0T) | ($9.2T) |
| Total loans, net | $184.2T | $190.1T | $176.2T | $179.1T |
| Other accounts receivable, net | $24.5T | $28.0T | $25.6T | $23.4T |
| Non-current assets held for sale | $18.3T | $105.2B | $101.2B | $92.8B |
| Investments in associates and joint ventures | $1.3T | $1.4T | $1.3T | $1.4T |
| Property, plant and equipment for own-use and given in operating lease, net | $7.0T | $4.7T | $4.5T | $4.8T |
| Right-of-use assets | $1.5T | $1.4T | $1.3T | $1.3T |
| Investment properties | $883.0B | $972.9B | $906.5B | $881.0B |
| Biological assets | $235.4B | $238.3B | $230.7B | $212.6B |
| Total Tangible assets | $9.6T | $7.2T | $7.0T | $7.2T |
| Concession arrangement rights | $13.5T | $14.3T | $13.6T | $13.2T |
| Goodwill | $2.1T | $2.2T | $2.2T | $2.2T |
| Other intangible assets | $3.0T | $2.8T | $2.4T | $2.0T |
| Total Intangibles | $18.5T | $19.3T | $18.1T | $17.5T |
| Current | $2.9T | $3.1T | $2.6T | $1.8T |
| Deferred | $1.4T | $1.6T | $1.3T | $1.9T |
| Total Income tax assets | $4.2T | $4.8T | $3.9T | $3.6T |
| Other assets | $386.4B | $538.9B | $465.6B | $608.6B |
| Total assets | $348.9T | $327.9T | $301.2T | $295.6T |
| Trading liabilities | $2.0T | $1.0T | $2.2T | $1.8T |
| Hedging derivative liabilities | $34.8B | $21.7B | $217.6B | $3.6B |
| Checking accounts | $23.6T | $24.6T | $23.8T | $25.9T |
| Savings accounts | $88.2T | $79.6T | $71.1T | $74.3T |
| Time deposits | $95.1T | $96.3T | $86.6T | $72.3T |
| Other deposits | $462.5B | $347.9B | $430.2B | $841.5B |
| Total Customers deposits | $207.4T | $200.9T | $182.0T | $173.3T |
| Interbank borrowings and overnight funds | $22.7T | $18.5T | $15.1T | $9.1T |
| Borrowings from banks and others | $24.6T | $28.1T | $22.2T | $30.3T |
| Bonds issued | $21.5T | $26.2T | $23.4T | $28.4T |
| Total financial obligations | $68.7T | $72.8T | $65.5T | $72.1T |
| Legal related | $155.4B | $192.5B | $217.7B | $229.2B |
| Non legal related | $834.2B | $910.1B | $865.6B | $998.0B |
| Total Provisions | $989.6B | $1.1T | $1.1T | $1.2T |
| Current | $203.9B | $247.5B | $268.3B | $228.8B |
| Line item | Dec 31, 2025 · FY | Dec 31, 2024 · FY | Dec 31, 2023 · FY | Dec 31, 2022 · FY |
|---|---|---|---|---|
| Net income before income tax of continuing operations | $4.6T | — | — | $6.3T |
| Depreciation of tangible assets and right-of-use assets | $597.9B | $588.3B | $557.1B | $559.9B |
| Amortization of intangible assets | $767.9B | $686.3B | $594.1B | $530.6B |
| Impairment losses on loans and other accounts receivable | $4.3T | $4.8T | $4.8T | $3.2T |
| Net interest income | ($7.9T) | ($7.3T) | ($6.3T) | ($7.7T) |
| Accrued dividends | ($126.7B) | ($148.5B) | ($126.3B) | ($119.9B) |
| Net gains on sales of non-current assets held for sale | ($9.9B) | ($21.5B) | ($48.0B) | ($9.7B) |
| Gain on sale of property plant and equipment for own-use and operating lease | ($131.9B) | ($75.5B) | ($344.7B) | ($140.2B) |
| Loss on sale of investment property | $28.4B | $14.4B | $22.2B | $17.3B |
| Gain on sale biological assets | ($5.2B) | — | — | — |
| Valuations and interest from concession agreements | ($2.8T) | ($2.9T) | ($3.9T) | ($5.1T) |
| Foreign exchange (gains) losses | ($585.0B) | $454.8B | ($2.3T) | $1.8T |
| Profit of equity accounted on investments in associates and joint ventures | ($350.9B) | ($378.4B) | ($371.4B) | ($372.8B) |
| Derivatives | $257.8B | ($415.6B) | $2.6T | ($1.5T) |
| Non-current assets held for sale | $1.6B | $4.7B | $268.0M | $76.0M |
| Investment properties | ($68.3B) | ($35.8B) | ($85.0B) | ($55.9B) |
| Biological assets | ($3.4B) | ($7.6B) | ($18.6B) | ($56.9B) |
| Trading assets | ($6.8T) | ($5.6T) | ($2.8T) | $545.5B |
| Accounts receivable | ($892.4B) | ($719.9B) | ($975.7B) | ($2.4T) |
| Derivatives | ($550.9B) | $238.5B | ($2.1T) | $1.4T |
| Other assets | ($6.7B) | ($136.8B) | ($78.3B) | $121.8B |
| Other liabilities and provisions | $2.7T | $1.1T | $1.4T | $462.9B |
| Employee benefits | ($12.9B) | $49.2B | ($27.5B) | $7.9B |
| Loans | ($17.7T) | ($14.0T) | ($7.6T) | ($27.8T) |
| Customer deposits | $24.8T | $14.8T | $15.4T | $17.8T |
| Interbank borrowings and overnight funds | $4.9T | $3.3T | $5.9T | ($1.4T) |
| Borrowings from banks and others | $931.8B | ($1.2T) | ($3.9T) | $8.7T |
| Interest received | $23.4T | $28.0T | $26.1T | $16.9T |
| Interest paid | ($17.7T) | ($21.4T) | ($21.5T) | ($10.6T) |
| Interest paid on leases | ($237.8B) | ($239.7B) | ($202.4B) | ($146.3B) |
| Income tax paid | ($2.2T) | ($2.0T) | ($2.0T) | ($1.5T) |
| Discontinued operation | ($2.0T) | — | — | — |
| Net cash provided by operating activities | $7.4T | $782.3B | $6.0T | ($222.1B) |
| Acquisition of property, plant and equipment for own use and operating lease | ($602.3B) | ($636.1B) | ($589.1B) | ($519.4B) |
| Acquisition of investment property | ($8.3B) | ($793.0M) | ($163.0M) | ($2.3B) |
| Additions of cost of biological assets | ($27.2B) | ($26.6B) | ($26.1B) | ($28.4B) |
| Concession contracts | $158.8B | $305.7B | $853.8B | — |
| Additions of others intangibles assets | ($660.3B) | ($658.6B) | ($683.5B) | ($598.2B) |
| Acquisition of investments at FVOCI | ($17.5T) | ($15.4T) | ($24.4T) | ($21.0T) |
| Proceeds from sale of investments at FVOCI | $13.7T | $12.0T | $25.7T | $23.5T |
| Proceeds from sale of own-use property and equipment and operating lease | $152.4B | $78.5B | $76.7B | $73.0B |
| Proceeds from sale of investment properties | $207.9B | $66.4B | $111.5B | $76.3B |
| Proceeds from sale of biological assets | $38.7B | $35.9B | $37.1B | $40.6B |
| Proceeds from sale of non-current assets held for sale | $75.2B | $49.7B | $61.7B | $41.6B |
| Purchases of financial assets at amortized cost | ($7.0T) | ($7.8T) | ($8.0T) | ($6.9T) |
Grupo Aval Acciones Y Valores S.A. score and earnings-call analysis · All covered companies
Figures as reported in SEC filings. General information, not investment advice.